b , Glucose tolerance test (GTT) and insulin during the GTT of the mice in A at 4 months of age (n = 7 Control, n = 6 Bmal1 -KO, and n = 5 Bmal1 -KO + NDI1)
Study findings The atlas showcased the varying efficacy and side effects of GLP-1RAs versus an antihyperglycemic class
Retatrutide Phase 2 Efficacy Data The phase 2 dose-ranging trial (ClinicalTrials.gov NCT04881760, published in the New England Journal of Medicine in 2023) enrolled 338 adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity, and randomized them to placebo or retatrutide 1 mg, 4 mg, 8 mg, or 12 mg weekly after a structured titration period of up to 24 weeks [1]
At the end of treatment, mice were euthanized by asphyxiation with CO 2 and peripheral blood, spleen single cell population were analyzed for the ROS, ferroptosis levels by DCF and Bodipy-C11 staining followed by flow cytometry analysis